CDH1 and breast carcinoma: miR-221/222 acts downstream of the oncogenic Ras-Raf-MEK-ERK pathway, increasing ZEB2 levels and consequently repressing E-cadherin by targeting the 3’UTR of the GATA family transcriptional repressor TRPS1, resulting in heightened EMT in basal-like breast cancer [62].